Baidu
map

Stroke:颅内多发动脉瘤的危险因素及临床结局!

2018-03-06 xing.T MedSci原创

由此可见,女性、年龄越大、动脉高血压、吸烟和家族性IA是MIA的主要危险因素。此外,MIA患者发生IA的风险增加。

颅内多发动脉瘤(MIAs)是脑血管造影较为常见的发现;然而,MIA的患病率在不同人群中有所差异。近日,卒中领域权威杂志Stroke上发表了一篇研究文章,研究人员试图阐明影响MIA患病率的危险因素以及临床结局。

研究人员系统地检索了PubMed、Scopus、EMBASE和Cochrane图书馆等数据库,查找了出版于2017年1月15日之前报告了MIA患病率和危险因素的文献。研究人员采用随机效应荟萃分析和多元回归分析来评估了个人、研究和人群特征的影响。

研究人员共纳入174个报告了MIA(平均患病率为20.1%,范围为2%-44.9%)的研究,其中含有134个研究人群,在1950至2015年间招募了86989例颅内动脉瘤患者。来自欧洲和北美的研究(P<0.001)以及最近招募年份的研究(P=0.046)与较高的MIA患病率独立相关。在荟萃分析中,MIA与女性(比值比[OR]为1.59;95%可信区间[CI]为1.4-1.8)、较高的患者年龄(>40岁;OR为1.6;95%CI为1.14-2.25)、高血压(OR为1.51;95%CI为1.17-1.94)、吸烟(OR为1.89;95%CI为1.37-2.6)和家族性IA(OR为2.02;95%CI为1.47-2.77)和从头形成(OR为3.92;95%CI为1.95-7.87)和初始IA增长(OR为3.47;95%CI为1.87-6.45)相关。只有在日本和韩国的纵向研究(OR为2.08,95%CI为1.46-2.96)中,MIA患者的蛛网膜下腔出血风险较高。

由此可见,女性、年龄越大、动脉高血压、吸烟和家族性IA是MIA的主要危险因素。此外,MIA患者发生IA的风险增加。

原始出处:

Ramazan Jabbarli,et al. Risk Factors for and Clinical Consequences of Multiple Intracranial Aneurysms A Systematic Review and Meta-Analysis.Stroke. 2018. https://doi.org/10.1161/STROKEAHA.117.020342

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1942937, encodeId=2173194293e34, content=<a href='/topic/show?id=dc9e43086ec' target=_blank style='color:#2F92EE;'>#多发动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43086, encryptionId=dc9e43086ec, topicName=多发动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Tue Jun 26 13:56:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843152, encodeId=802b1843152d1, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Aug 08 08:56:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293616, encodeId=1d5f293616c6, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Mar 06 19:05:27 CST 2018, time=2018-03-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1942937, encodeId=2173194293e34, content=<a href='/topic/show?id=dc9e43086ec' target=_blank style='color:#2F92EE;'>#多发动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43086, encryptionId=dc9e43086ec, topicName=多发动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Tue Jun 26 13:56:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843152, encodeId=802b1843152d1, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Aug 08 08:56:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293616, encodeId=1d5f293616c6, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Mar 06 19:05:27 CST 2018, time=2018-03-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1942937, encodeId=2173194293e34, content=<a href='/topic/show?id=dc9e43086ec' target=_blank style='color:#2F92EE;'>#多发动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43086, encryptionId=dc9e43086ec, topicName=多发动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83a4244, createdName=swallow, createdTime=Tue Jun 26 13:56:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1843152, encodeId=802b1843152d1, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Aug 08 08:56:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=293616, encodeId=1d5f293616c6, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Mar 06 19:05:27 CST 2018, time=2018-03-06, status=1, ipAttribution=)]
    2018-03-06 131****1460

    学习了受益匪浅

    0

Baidu
map
Baidu
map
Baidu
map